ERCS

U.S. DoD selects CCC, Thornhill Medical for critical care devices

Retrieved on: 
Thursday, January 11, 2024
CCC, Anesthesia, Oxygen, FAS, DLA, Armed, Ministry of Health, ERCS, USD, Vital signs, Nursing care plan, Ministry, USMC, Suction

Based in Toronto, Ontario, Thornhill Medical is a global innovator focused on respiratory and oxygen-related science and technology.

Key Points: 
  • Based in Toronto, Ontario, Thornhill Medical is a global innovator focused on respiratory and oxygen-related science and technology.
  • Marking its 20th year in 2024, Thornhill Medical is transforming the delivery of critical care and patient transport in austere and unpredictable combat casualty care, humanitarian and emergency environments.
  • Through its U.S. DoD Prime Contractor service, CCC partners with Canadian businesses like Thornhill Medical to supply the U.S. DoD with made in Canada solutions.
  • “We are pleased to contract with CCC to supply the U.S. DoD with our combat critical care technologies.

Thornhill Medical’s MOVES® SLC™ deployed as part of the first En-Route Care System (ERCS) aboard the U.S. Navy’s Eisenhower Strike Group (IKECSG)

Retrieved on: 
Tuesday, November 28, 2023
Trauma, Suction, ERCS, Oxygen, Commander, IKE, Patient, Nursing care plan, Vital signs

Deployed on October 14, 2023, the ERCS allows the U.S. Navy to evacuate critically ill patients while maintaining full medical capabilities back on the ship.

Key Points: 
  • Deployed on October 14, 2023, the ERCS allows the U.S. Navy to evacuate critically ill patients while maintaining full medical capabilities back on the ship.
  • As a component within the ERCS, MOVES® SLC™ enables expanded care capabilities advanced technology that is smaller, lighter, more durable, flexible, easy to maintain, and less reliant on supply chain.
  • MOVES® SLC™ is a portable life support system that provides advanced critical care capabilities in extreme or austere environments and in transport or evacuation.
  • “We are excited to expand the strike group’s medical response capabilities with the addition of ERCS,” said Cmdr.

Innovation Refunds' CEO Howard Makler Discusses How Businesses Can Protect Themselves From Bad Players in the Employee Retention Credit Industry

Retrieved on: 
Tuesday, December 13, 2022
PPP, Human, Government, Small business, Congress, ERC, Confusion, Employment, Provisions of the Affordable Care Act, Knowledge, Education, CARES Act, Research, ERCS, COVID-19, Paycheck Protection Program, Online shopping, Health insurance

Congress launched the Employee Retention Credit (ERC) program under the CARES Act in 2020 in response to the COVID-19 outbreak in the United States.

Key Points: 
  • Congress launched the Employee Retention Credit (ERC) program under the CARES Act in 2020 in response to the COVID-19 outbreak in the United States.
  • Certain companies have qualified for payroll tax refunds of up to $26,000 per employee, even if they have received Paycheck Protection Program (PPP) funds.
  • However, per Makler, there are a few key indicators that business owners can use to differentiate real ERC companies from the bad players.
  • Innovation Refunds and other legitimate ERC companies only request payment from small businesses after they have received their tax credit returns," said Makler.

ERYTECH Provides Business and Financial Update for the First Half of 2022

Retrieved on: 
Monday, September 12, 2022
ERCS, Neurotransmission, Biologics license application, FDA, Food, Sale, Intention, Company, Pancreatic cancer, Review, Red blood cell, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Catalent, Seminal vesicles, TNBC, Committee, Nasdaq, Conference call, Acute lymphoblastic leukemia, Science, BLA, ALL, Triple-negative breast cancer, Webcast, GMP, Retail, Pharmaceutical industry, Conference

2022 has been so far, and will continue to be, a year of deep strategic refoundation for ERYTECH, said Gil Beyen, Chief Executive Officer of ERYTECH.

Key Points: 
  • 2022 has been so far, and will continue to be, a year of deep strategic refoundation for ERYTECH, said Gil Beyen, Chief Executive Officer of ERYTECH.
  • In April 2022, ERYTECH sold its commercial-scale cell therapy manufacturing facility in Princeton, New Jersey, to Catalent, for a total consideration of $44.5 million.
  • ERYTECH maintained its GMP-approved manufacturing site in Lyon, France and its core expertise to continue innovating in cell therapy.
  • Key financial figures for the first half of 2022 compared with the same period of the previous year are summarized below:

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Enservco Corporation (ENSV) Investors With Losses Exceeding $300K of Class Action and Last Few Hours to Actively Participate

Retrieved on: 
Tuesday, July 19, 2022
Class Action Lawsuit, Professional Services, Legal, SEC, U.S. Securities and Exchange Commission, Disclosure, Mission statement, Annual report, Review, Securities Exchange Act of 1934, NYSE, Lists of schools in England, LLC, ENSV, Complaint, ERCS, Company, Court, Security (finance)

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Key Points: 
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

DEADLINE ALERT for PEGA, HMBL, OKTA, and ENSV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, July 18, 2022
Research, SEC, Law, Investment, Disclosure, Mission statement, Time, Annual report, GLOBE, Twitter, Lists of schools in England, Defendant, Lawsuit, ERCS, Suite, Company, Mail, Public relations, Okta

LOS ANGELES, July 18, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, July 18, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enservco Corporation (ENSV)

Retrieved on: 
Monday, July 18, 2022
Class Action Lawsuit, Professional Services, Legal, SEC, Relevant, News, Law, Form 10-K, Disclosure, Mission statement, Annual report, Time, NYSE, Twitter, Lists of schools in England, ENSV, ERCS, Suite, Company, Court, Defendant, Public relations

The Law Offices of Frank R. Cruz reminds investors of the upcoming July 19, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Enservco Corporation (Enservco or the Company) (NYSE: ENSV ) securities between May 13, 2021 and April 18, 2022, inclusive (the Class Period).

Key Points: 
  • The Law Offices of Frank R. Cruz reminds investors of the upcoming July 19, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Enservco Corporation (Enservco or the Company) (NYSE: ENSV ) securities between May 13, 2021 and April 18, 2022, inclusive (the Class Period).
  • On this news, Enservcos stock fell $0.45, or 12.3%, to close at $3.21 per share on March 28, 2022, thereby injuring investors.
  • Enservcos stock fell $0.21, or 7.8%, to close at $2.49 per share on April 1, 2022, thereby injuring investors further.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enservco Corporation of Class Action Lawsuit and Upcoming Deadline – ENSV

Retrieved on: 
Sunday, July 17, 2022
SEC, Relevant, News, U.S. Securities and Exchange Commission, District court, File, Person, Form 10-K, Disclosure, Mission statement, SEC Rule 10b-5, Annual report, LLP, Economy, Lists of action films, GLOBE, Securities Exchange Act of 1934, Income, NYSE, Lists of schools in England, LLC, ENSV, Exercise, District, Complaint, Ext, ERCS, Company, Coronavirus, Court, Pomerantz, Online gambling, Bank, Cryptocurrency, Renewable energy

NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enservco Corporation (Enservco or the Company) (NYSE: ENSV) and certain of its officers.

Key Points: 
  • NEW YORK, July 17, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enservco Corporation (Enservco or the Company) (NYSE: ENSV) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enservco Corporation (ENSV)

Retrieved on: 
Friday, July 15, 2022
SEC, Relevant, News, Form 10-K, Disclosure, Mission statement, Annual report, Time, GLOBE, NYSE, Lists of schools in England, ENSV, GPM, ERCS, LOS, Suite, Company, Court, Defendant, Pharmaceutical industry

LOS ANGELES, July 15, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 19, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Enservco Corporation (“Enservco” or the “Company”) (NYSE: ENSV) securities between May 13, 2021 and April 18, 2022, inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, July 15, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming July 19, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Enservco Corporation (Enservco or the Company) (NYSE: ENSV ) securities between May 13, 2021 and April 18, 2022, inclusive (the Class Period).
  • On this news, Enservcos stock fell $0.45, or 12.3%, to close at $3.21 per share on March 28, 2022, thereby injuring investors.
  • Enservcos stock fell $0.21, or 7.8%, to close at $2.49 per share on April 1, 2022, thereby injuring investors further.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

ENSERVCO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enservco Corp. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, July 16, 2022
Class Action Lawsuit, Professional Services, Legal, SEC, Relevant, News, U.S. Securities and Exchange Commission, District court, File, Person, Disclosure, Form 10-K, Mission statement, Annual report, Economy, Income, NYSE, Telephone, Lists of schools in England, Jeanne Eagels, ENSV, LLC, District, ERCS, P.C, Company, Coronavirus, Court, Security (finance), Bank, Online gambling, Cryptocurrency, Renewable energy

Investors have until July 19, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until July 19, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Enservco, through its subsidiaries, provides well enhancement and fluid management services to the onshore oil and natural gas industry in the United States.
  • Recently, the Company has employed several tactics in an apparent effort to strengthen its balance sheets.
  • Enservcos Chief Executive Officer, Defendant Richard A. Murphy, is managing member of Cross River Capital Management, LLC, the general partner of Cross River Partners.